COMPARISON OF A NEW FORMULATION OF GOSERELIN (Pepti 3.6 mg) to Zoladex® 3.6 mg

NCT04428684 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysfunctional Uterine Bleeding

Interventions

DRUG: Pepti 3.6 mg

Sponsor

Peptigroupe Inc.